<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tsang RS</submitter><funding>Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation</funding><funding>Medical Research Council</funding><pagination>134-148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11100448</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(4)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines.&lt;h4>Design&lt;/h4>We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General Practitioners national sentinel network. We compared the AEIs that occurred seven days before and after receiving the COVID-19 vaccinations to background levels between 1 October 2020 and 12 September 2021.&lt;h4>Setting&lt;/h4>England, UK.&lt;h4>Participants&lt;/h4>Individuals experiencing AEIs after receiving first and second doses of COVID-19 vaccines.&lt;h4>Main outcome measures&lt;/h4>AEIs</pubmed_abstract><journal>Journal of the Royal Society of Medicine</journal><pubmed_title>Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study.</pubmed_title><pmcid>PMC11100448</pmcid><funding_grant_id>HDRUK2021.0056</funding_grant_id><funding_grant_id>MC_PC_20058</funding_grant_id><funding_grant_id>MC_PC_20029</funding_grant_id><pubmed_authors>O'Reilly D</pubmed_authors><pubmed_authors>Agrawal U</pubmed_authors><pubmed_authors>Chuter A</pubmed_authors><pubmed_authors>Richard Hobbs FD</pubmed_authors><pubmed_authors>Joy M</pubmed_authors><pubmed_authors>Williams J</pubmed_authors><pubmed_authors>Victor W</pubmed_authors><pubmed_authors>Anand SN</pubmed_authors><pubmed_authors>Beggs J</pubmed_authors><pubmed_authors>Sheikh A</pubmed_authors><pubmed_authors>Howsam G</pubmed_authors><pubmed_authors>Kar D</pubmed_authors><pubmed_authors>Lusignan S</pubmed_authors><pubmed_authors>Akbari A</pubmed_authors><pubmed_authors>Robertson C</pubmed_authors><pubmed_authors>Hinton W</pubmed_authors><pubmed_authors>Tsang RS</pubmed_authors><pubmed_authors>Mayor N</pubmed_authors><pubmed_authors>Owen RK</pubmed_authors><pubmed_authors>Bradley DT</pubmed_authors><pubmed_authors>Byford R</pubmed_authors><pubmed_authors>Murphy S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study.</name><description>&lt;h4>Objectives&lt;/h4>To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines.&lt;h4>Design&lt;/h4>We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General Practitioners national sentinel network. We compared the AEIs that occurred seven days before and after receiving the COVID-19 vaccinations to background levels between 1 October 2020 and 12 September 2021.&lt;h4>Setting&lt;/h4>England, UK.&lt;h4>Participants&lt;/h4>Individuals experiencing AEIs after receiving first and second doses of COVID-19 vaccines.&lt;h4>Main outcome measures&lt;/h4>AEIs</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-04-12T15:30:34.516Z</modification><creation>2026-04-07T13:18:01.449Z</creation></dates><accession>S-EPMC11100448</accession><cross_references><pubmed>37921538</pubmed><doi>10.1177/01410768231205430</doi></cross_references></HashMap>